JBS N.V. (JBS)vsArcadia Biosciences Inc (RKDA)
JBS
JBS N.V.
$15.75
+2.67%
CONSUMER DEFENSIVE · Cap: $15.80B
RKDA
Arcadia Biosciences Inc
$1.70
-0.06%
CONSUMER DEFENSIVE · Cap: $3.71M
Smart Verdict
WallStSmart Research — data-driven comparison
JBS N.V. generates 1626583% more annual revenue ($84.15B vs $5.17M). JBS leads profitability with a 2.5% profit margin vs -98.0%. JBS earns a higher WallStSmart Score of 51/100 (C-).
JBS
Buy51
out of 100
Grade: C-
RKDA
Hold37
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-132.0%
Fair Value
$7.00
Current Price
$15.75
$8.75 premium
Intrinsic value data unavailable for RKDA.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Every $100 of equity generates 24 in profit
Attractively priced relative to earnings
Reasonable price relative to book value
Reasonable price relative to book value
Earnings expanding 28.5% YoY
Areas to Watch
2.5% margin — thin
Earnings declined 16.2%
Elevated debt levels
Smaller company, higher risk/reward
Weak financial health signals
ROE of -64.6% — below average capital efficiency
Revenue declined 15.3%
Comparative Analysis Report
WallStSmart ResearchBull Case : JBS
The strongest argument for JBS centers on Return on Equity, P/E Ratio, Price/Book. Revenue growth of 13.4% demonstrates continued momentum.
Bull Case : RKDA
The strongest argument for RKDA centers on Price/Book, EPS Growth.
Bear Case : JBS
The primary concerns for JBS are Profit Margin, EPS Growth, Debt/Equity. Debt-to-equity of 2.56 is elevated, increasing financial risk. Thin 2.5% margins leave little buffer for downturns.
Bear Case : RKDA
The primary concerns for RKDA are Market Cap, Piotroski F-Score, Return on Equity.
Key Dynamics to Monitor
JBS profiles as a value stock while RKDA is a turnaround play — different risk/reward profiles.
JBS is growing revenue faster at 13.4% — sustainability is the question.
JBS generates stronger free cash flow (543M), providing more financial flexibility.
Monitor PACKAGED FOODS industry trends, competitive dynamics, and regulatory changes.
Bottom Line
JBS scores higher overall (51/100 vs 37/100) and 13.4% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
JBS N.V.
CONSUMER DEFENSIVE · PACKAGED FOODS · USA
JBS N.V., is a protein and food company globally. The company is headquartered in Amstelveen, Netherlands.
Arcadia Biosciences Inc
CONSUMER DEFENSIVE · PACKAGED FOODS · USA
Arcadia Biosciences, Inc. is dedicated to developing various crop productivity traits primarily in hemp, wheat, and soybeans. The company is headquartered in Davis, California.
Visit Website →Compare with Other PACKAGED FOODS Stocks
Want to dig deeper into these stocks?